3,4-diaminofurazan,
3,4-Diaminofurazan,
1,2,5-Oxadiazole-3,4-diamine,
17220-38-1,
Furazandiamine,
3,4-Diamino-1,2,5-oxadiazole,
3,4-Diaminofurazan, 97%,
JHJVSUCUNFXIHN-UHFFFAOYSA-N,
diaminofurazan,
ZERO/000235,
4,5-Diaminofurazan,
MFCD00138084,
3,4-diaminofurazane,
furazan-3,4-diamine,
PubChem21086,
AC1LBL0P,
AC1Q4XMG,
ACMC-209e40,
AC1Q538X,
ARONIS004561,
SCHEMBL1458607,
Jsp003515,
CTK0H7572,
KS-00000NCZ,
KS-00003XAW,
DTXSID00336977,
ALBB-010793,
BCP00227,
ZINC3882148,
1,2,5-Oxadiazole-3,4-diamine #,
8855AA,
ANW-22558,
BBL008366,
CD-624,
GEO-00916,
SBB000032,
STK046487,
4-amino-1,2,5-oxadiazol-3-ylamine,
AKOS000266508,
AC-1480,
CS-W007462,
MCULE-9556144390,
RP18684,
RS-0105,
TRA0039751,
VZ34872,
AJ-46659,
AK-27939,
BC219864,
SC-20758,
ST024392,
AB0069849,
DB-006273,
ST2408420,
TC-030094,
4CH-016719,
BB 0218174,
D4030,
EU-0033219,
FT-0600256,
C-6247,
220D381,
A811379,
I14-6289,
W-200162,
C2H4N4O,
KST-1B0965,
AR-1B5453,
CID537677,
ACN-025520,
3,4-Diaminofurazan, 98% - 1G 1g,
(1,3-benzodioxol-5-ylmethyl)(1-naphthylmethyl)amine hydrobromide,
17299-25-1,
17213-58-0,